SE

Biosensor Applications Sweden Ab

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 20.0


Forward Citations = 15

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Jan Smith (3 out of 5 patents)

silverMedal Per Månsson (3 out of 5 patents)

bronzeMedal Teodor Aastrup (2 out of 6 patents)

4.  Henrik Andersson (2 out of 2 patents)

5.  Kjeld Jensen (2 out of 2 patents)

6.  Zelig Eshhar (1 out of 13 patents)

7.  Itamar Willner (1 out of 13 patents)

8.  Ann-Sofie Johansson (1 out of 1 patent)

9.  Björn Sandén (1 out of 1 patent)

10.  Shahin Loniakan (1 out of 1 patent)

11.  Ann-Charlotte Hellgren (1 out of 1 patent)

12.  Per Månsson (1 out of 3 patents)

13.  Björn Sanden (0 patent)

14.  Jan c/o Christer Rutberg Smith (0 patent)

15.  Per Maansson (0 patent)


5 patents:

Company Overview
Biosensor Applications Sweden Ab is a leading provider of cutting-edge biosensor technologies for various applications in the healthcare, pharmaceutical, and environmental sectors. With a focus on innovation and quality, the company offers a range of biosensors that enable accurate and real-time measurement of various biomolecules. Backed by a team of experts, Biosensor Applications Sweden Ab is committed to delivering high-performance biosensor solutions to meet the evolving needs of its customers.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#82 in

#113 in Sweden

SE
SE
Forward Citations = 15

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosensor Applications Sweden Ab. Retrieved from https://idiyas.com/company/biosensor-applications-sweden-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…